Interleukin Deficiency Disorder Patient Responses to COVID-19 Infections

Gillis, Bruce S. and Gavin, Igor M. and Barkhordar, Farnaz and Mohapatra, Gayatry and Jin, Ming and Behm, Frederick G. (2021) Interleukin Deficiency Disorder Patient Responses to COVID-19 Infections. Journal of Advances in Medicine and Medical Research, 33 (8). pp. 40-45. ISSN 2456-8899

[thumbnail of 3991-Article Text-7778-1-10-20220930.pdf] Text
3991-Article Text-7778-1-10-20220930.pdf - Published Version

Download (190kB)

Abstract

Interleukin Deficiency Disorder Patient Responses to COVID-19 Infections Bruce S. Gillis https://orcid.org/0000-0001-5423-3828 Igor M. Gavin Farnaz Barkhordar Gayatry Mohapatra Ming Jin Frederick G. Behm

Background: The chemokine, cytokine interleukin deficiency disorder defines the immune deficiency disease of fibromyalgia and a reduced ability to produce IL-6 and IL-8. Recent research has demonstrated improved outcomes in COVID-19 infections treated with IL-6 antagonists.9 These fibromyalgia cytokine deficient patients were screened for COVID-19 infections and associated morbidity and mortality rates. Methods: Two cohorts of FM/a test positive fibromyalgia patients were evaluated. Initially, 4,631 patients were screened to determine the occurrence of known COVID-19 infections. Subsequently, 2,195 FM/a test positive patients underwent COVID-19 antibody testing. Results: A total of 7,375 fibromyalgia patients were screened for the occurrence of COVID-19 infections. Of these, 4,631 individuals responded to an email-based inquiry to determine the occurrence of documented COVID-19 infections. Only 10 reported having symptoms consistent with and were diagnosed with COVID-19 by a healthcare professional, making for an incidence of .22%. Another 2,195 fibromyalgia patients completed health questionnaires and COVID-19 antibody testing and 82 had evidence of COVID-19 antibodies with 42 exhibiting symptoms and confirmed diagnoses. Of the remaining, 23 were asymptomatic. There were no deaths and only 1 hospitalization in this group. Conclusion: Individuals with FM/a test positive fibromyalgia have a reduced ability to produce IL-6 and IL-8 which play significant roles in the cytokine storm complications associated with COVID-19 infections. When screened for evidence of past COVID-19 infections, these patients experienced an extremely low incidence of COVID-19 infections based upon antibody testing, there were no mortalities and the level of morbidity was significantly below what has been reported in general populations.
04 07 2021 40 45 10.9734/jammr/2021/v33i830884 https://journaljammr.com/index.php/JAMMR/article/view/3991 https://www.journaljammr.com/index.php/JAMMR/article/download/30884/57829 https://www.journaljammr.com/index.php/JAMMR/article/download/30884/57829 https://www.journaljammr.com/index.php/JAMMR/article/download/30884/57831

Item Type: Article
Uncontrolled Keywords: Fibromyalgia; COVID-19; IL-6.
Subjects: Library Eprints > Medical Science
Depositing User: Managing Editor
Date Deposited: 10 Nov 2022 05:26
Last Modified: 04 Jul 2025 03:40
URI: http://scholar.promo4article.com/id/eprint/98

Actions (login required)

View Item
View Item